Skip to main navigation Skip to search Skip to main content

EFFICACY AND SAFETY OF TOCILIZUMAB (TCZ) IN PATIENTS WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA): 2-YEAR DATA FROM TENDER, A PHASE 3 CLINICAL TRIAL

F. De Benedetti, H. Brunner, N. Ruperto, A. Kenwright, C. Devlin, I. Calvo, R. Cuttica, A. Ravelli, R. Schneider, D. Eleftheriou, C. Wouters, R. Xavier, L. Zemel, E. Baildam, R. Burgos-Vargas, P. Dolezalova, S. M. Garay, R. Joos, A. Grom, N. WulffraatZ. Zuber, F. Zulian, D. Lovell, A. Martini

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)425-425
JournalAnnals of the Rheumatic Diseases
Volume71
Publication statusPublished - Jun 2013

Cite this